Engendering Support: The Power of Family for Transgender Youth
The estimated time to complete this course is 90 minutes. Learners will be asked to complete an activity post-assessment with a pass score of 75%.
Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
Healthcare professionals and medical students.
- Discuss how stigma and prejudice impact patient, family, and caregiver attitudes towards working with transgender, gender nonconforming, gender expansive and non-binary youth.
- Describe the impact of family affirmation on transchildren.
- Discuss how Autism Spectrum Disorder impacts gender identity.
Date of original release: November 7, 2020
Most recent review/update: November 7, 2020
Termination date: November 6, 2023
Peter T. Daniolos, MD
Dr. Daniolos is a Clinical Professor in Child and Adolescent Psychiatry at The University of Iowa Children’s Hospital, where he serves as the Training Director of the Child and Adolescent Psychiatry Residency Training Program, and provides clinical evaluations as part of the University of Iowa Autism Center’s Child and Adolescent Psychiatry team. He also runs the Gender Evaluation Program (GEP) in Child and Adolescent Psychiatry, working in close collaboration with the University of Iowa Hospital and Clinics’ LGBT Clinic at Iowa River Landing.
Prior to moving to Iowa, he served as the Training Director for the Child and Adolescent Psychiatry fellowship at Children’s National Medical Center/ The George Washington University Center, and the medical director of the Center for Autism Spectrum Disorders, where he worked with a multidisciplinary team engaged in the diagnostic evaluation and treatment of autism spectrum youth.
He attended the University of Denver as an undergraduate, followed by medical school in his home state at the University of North Dakota. He then did his Psychiatry residency at Duke, followed by his Child and Adolescent Psychiatry fellowship at Harvard/The Cambridge Hospital.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.5 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This enduring materials activity has been reviewed and approved for 1.5 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Jackie Ha, DO'23, planning committee member
- Amanda Hale, DO'23, planning committee member
- Helena Mica, MS, MA, planning committee member
- Samantha Schmitz, DO'23, planning committee member
- Meta Williams, DO'23, planning committee member
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.
- Peter T. Daniolos, MD, speaker, has no financial conflicts but does intend to discuss off-label use of a commercial product.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.50 AMA PRA Category 1 Credits™
- 1.50 AOA Category 2B
- 1.50 CE Contact Hour(s)
- 1.50 IBON